Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity

Journal of Immunology

Volumn 161, Issue 11, 1998, Pages 6238-6244

  Cao, Xuetao ^a   Zhang, Weiping ^a   He, Long ^a   Xie, Zhifang ^a   Ma, Shihua ^a   Tao, Qun ^a   Yu, Yizhi ^a   Hamada, Hirofumi ^b   Wang, Jianli ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b The Japan Foundation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTACTIN; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; BONE MARROW CELL; CHEMOTAXIS; DENDRITIC CELL; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOREGULATION; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ADENOVIRIDAE; ANIMALS; ANTIGENS, NEOPLASM; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CARCINOMA, LEWIS LUNG; CELL LINE; CHEMOKINES, C; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INJECTIONS, SUBCUTANEOUS; LYMPHOCYTE DEPLETION; LYMPHOKINES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OLIGOPEPTIDES; SIALOGLYCOPROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0032400965     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Steinman, R. M. 1991. The dendritic cells system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
2. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
3. Caux, C. C. Dezutter-Dambuyant, D. Schmitt, and J. Banchereau. 1992. GMCSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360:258.
4. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180.83.
5. Young, J. W., and K. Inaba. 1996. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J. Exp. Med. 183:7.
6. Girolomoni, G., and P. Ricciardi-Castagnoli. 1997. Dendritic cells hold promise for immunotherapy. Immunol. Today 18:102.
7. Flamand, V., T. Sornasse, K. Thielemans, C. Demnet, M. Bakkus, H. Bazin, F. Tielemans, O. Leo. J. Urbain, and M. Moser. 1994. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24:605.
8. Porgador, A., D. Snyder, and E. Gilboa. 1996. Induction of antitumor immunity using bone marrow-generated dendritic cells. J. Immunol. 156:2918.
9. Paglia, P., M. Chiodoni, M. Rodolfo, and M. P. Colombo. 1996. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 283:317.
10. Zitvogel, L., J. Mayordomo, T. Tjandrawan, A. Deleo, M. Clarke, M. Lotze, and W. J. Storkus. 1996. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183:87.
11. Ashley, D. M., B. Faiola, S. Nair, L. P. Hale, D. D. Bigner, and E. Gilboa. 1997. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J. Exp. Med. 186:1177.
12. Cao, X., W. Zhang, X. Huang, and J. Wang. 1997. Enhanced antitumor effects of tumor antigen-pulsed dendritic cells by their transfection with GM-CSF. Sci. China Ser. C 40:539.
13. Zitvogel, L., B. Couderc, J. I. Mayordomo, P. D. Robbins, M. T. Lotze, and W. J. Storkus. 1996. IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo. Ann. NY Acad. Sci. 795:284.
14. Hsu Frank F. J. J., C. Benike, F. Fagnoni, T. Liles, D. Czerwinski, B. Taidi, E. G. Engleman, and R. Levy. 1996. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed antigen-pulsed dendritic cells. Nat. Med. 2:52.
15. Porgador, A., and E. Gilboa. 1995. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182:255.
16. Mayordomo, J., T. Zorina, W. J. Storkus, L. Zitvogel, C. Celluzzi, L. Falo, C. Melief, S. Ildstad, W. M. Kast, A. B. Deleo, and M. Lotze. 1995. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nat. Med. 1:1297.
17. Ossevoort, M. A., M. Feltkamp, K. van Veen, C. Melief, and W. Kast. 1995. Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumor. J. Immunother. 18:86.
18. Celluzzi, C., J. I. Mayordomo, W. J. Storkus, M. T. Lotze, and J. L. D. Falo. 1996. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 183:283.
19. Bakker, A., G. Marland, A. J. de Boer, R. J. Huijbens, E. H. Danen, and G. J. Adema. 1995. Generation of anti-melanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res. 55:5330.
20. Reeves, M., R. Royal, J. Lam, S. A. Rosenberg, and P. Hwu. 1996. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res. 56:5672.
21. Bello-Fernandez, C., M. Matyash, H. Strobl, W. F. Pickl, O. Majdic, S. D. Lyman, and W. Knapp. 1997. Efficient retrovirus-mediated gene transfer of dendritic cells generated from CD34+ cord blood cells under serum-free conditions. Hum. Gene Ther. 8:1651.
22. Szabolcs, P., H. F. Gallardo, D. H. Clocon, M. Sadelain, and J. W. Young. 1997. Retrovirally transduced human dendritic cells express a normal phenotype and potent T-cell stimulatory capacity. Blood 151:2160.
23. Aicher, A., J. Westermann, S. Cayeux, G. Willimsky, K. Daemen, T. Blankenstein, W. Uckert, B. Dorken, and A. Pezzutto. 1997. Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells. Exp. Hematol. 25: 39.
24. Specht, J. M., G. Wang, M. T. Do, J. S. Lam, R. E. Royal, M. E. Reeves, S. A. Rosenberg, and P. Hwu. 1997. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J. Exp. Med. 186:1213.
25. Song, W., H. Kong, H. Carpenter, H. Torii, R. Granstein, S. Rafii, M. Moore, and R. G. Crystal. 1997. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J. Exp. Med. 186:1247.
26. Brossart, P., A. W. Goldrath, E. A. Butz, S. Martin, and M. J. Bevan. 1997. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J. Immunol. 158:3270.
27. Arthur, J. F., L. H. Butterfield, M. D. Roth, L. A. Bui, S. M. Kiertscher, R. Lau, S. Dubinett, J. Glaspy, W. H. McBride, and J. S. Economou. 1997. A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther. 4:17.
28. Condon, C., S. C. Watkins, C. M. Celluzzi, K. Thompson, and L. D. Falo. 1996. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2:1122.
29. Boczkowski, D., S. Nair, D. Snyder, and E. Gilboa, 1996. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184:465.
30. Gong, J., D. Chen, M. Kashiwaba, and D. Kufe. 1997. Induction of antitumor activity by immunization with fusions of dendritic cells and carcinoma cells. Nat. Med. 3:558.
31. Kupiec-Weglinski, J. W., J. M. Austyn, and P. J. Morris. 1988. Migration patterns of dendritic cells in the mouse: traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues. J. Exp. Med. 167:632.
32. Austyn, J. M., J. W. Kupiec-Weglinski, D. F. Hankins, and P. J. Morris. 1988. Migration patterns of dendritic cells in the mouse: homing to T cell-dependent areas of spleen, and binding within marginal zone. J. Exp. Med. 167:646.
33. Fossum, S. 1989. Lymph-borne dendritic leukocytes do not recirculate, but enter the lymph node paracortex to become interdigitating cells. Scand. J. Immunol. 27:97.
34. Kudo, S., K. Matsuno, T. Ezaki, and M. Ogawa. 1997. A novel migration pathway for rat dendritic cells from the blood: hepatic sinusoid-lymph translocation. J. Exp. Med. 135:777.
35. Steinman, R. M., M. Pack, and K. Inaba. 1997. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156:25.
36. Xu, L. L., M. Warren, W. Rose, W. Gong, and J. Wang. 1996. Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro. J. Leukocyte Biol. 60:365.
37. Godiska, R., D. Chantry, C. J. Raport, S. Sozzani, P. Allavena, D. Leviten, A. Mantovani, and P. W. Gray. 1997. Human macrophage derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte derived dendritic cells, and natural killer cells. J. Exp. Med. 185:1595.
38. Sozzani, S., W. Luini, A. Borsatti, N. Polentarutti, D. Zhou, L. Piemonti, G. D. Amico, C. A. Power, T. N. C. Wells, M. Gobbi, P. Allavena, and A. Mantovani. 1997. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J. Immunol. 159:1993.
39. Greaves, D. R., W. Wang, D. J. Dairaghi, M. C. Dieu, B. de Saint-Vis, K. Franz-Bacon, D. Rossi, C. Caux, T. McClanaban, S. Gordon, A. Zlotnik, and T. J. Schall. 1997. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3 alpha and is highly expressed in human dendritic cells. J. Exp. Med. 186:837.
40. Power, C. A., D. J. Church, A. Meyer, S. Alouani, A. E. Proudfoot, I. Clark-Lewis, S. Sozzani, A. Mantovani, and T. N. C. Wells. 1997. Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3 alpha from lung dendritic cells. J. Exp. Med. 186:825.
41. Zhou, L. J., and T. F. Tedder. 1995. A distinct pattern of cytokine gene expression by human CD83(+) blood dendritic cells. Blood 86:3295.
42. Mohamdzadeh, M., N. Poltorak, P. Bergstresser, B. Beutler, and A. Takashima. 1996. Dendritic cells produce macrophage inflammatory protein-1 γ, a new member of the CC chemokine family. J. Immunol. 156:3102.
43. Adema, G. J., F. Hartgers, R. Verstraten, E. de Vries, G. Marland, S. Menon, J. Foster, U. Xu, P. Nooyen, T. McClanahan, K. B. Bacon, and C. G. Figdor. 1997. A dendritic-cell-derived C-C chemokine that preferentially attracts naïve T cells. Nature 387:713.
44. Kelner, G. S., J. Kennedy, K. B. Bacon, S. Kleyensteuber, D. A. Largaespada, N. A. Jenknis, N. G. Copeland, J. F. Bazan, K. W. Moore, T. J. Schall, and A. Zlotnik. 1994. Lymphotactin: a cytokine that represents a new class of chemokine. Science 266:1395.
45. Kennedy, J., G. S. Keiner, S. Kleyensteuber, T. J. Schall, M. C. Weiss, H. Yssel, P. V. Schneider, B. G. Cocks, K. B. Bacon, and A. Zlotnik. 1995. Molecular cloning and functional characterization of human lymphotactin. J. Immunol. 155: 203.
46. Hedrick, J., V. Saylor, D. Figueroa, L. Mizoue, Y. Xu, S. Menon, J. Abrams, T. Handel, and A. Zlotnik. 1997. Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. J. Immunol. 158:1533.
47. Dilloo, D., K. Bacon, W. Holeden, W. Zhong, S. Burdach, A. Zlotnik, and M. Brenner. 1996. Combined chemokine and cytokine gene transfer enhances antitumor immunity. Nat. Med. 2:1090.
48. Mandelboim, O., G. Berke, M. Fridkin, M. Feldman, M. Eisenstein, and L. Eisenbach. 1994. CTL induction by a tumor-associated antigen octapeptide derived from a murine lung carcinoma. Nature 369:67.
49. Rotzschke, O., K. Falk, S. Stevanovic, G. Jung, P. Walden, and H. G. Rammensee. 1991. Extract prediction of a natural T cell epitope. Eur. J. Immunol. 21:2891.
50. Lan, K., F. Kanai, Y. Shiratori, S. Okabe, Y. Yoshida, H. Wakimoto, H. Hamada, T. Tanaka, M. Ohashi, and M. Omata. 1996. Tumor-specific gene expression in carcinoembryonic antigen-producing gastric cancer cells using adenovirus vectors. Gastroenterology 111:1241.
51. Miyake, S., M. Makimura, Y. Kanegae, S. Harada, Y. Sato, K. Takamori, C. Tokuda, and I. Saito. 1996. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. USA 93:1320.
52. + T lymphocytes and monocytes. J. Immunol. 138: 3817.
53. Mandelboim, O., M. Feldman, and L. Eisenbach. 1992. H-2K double transfectants of tumor cells as antimetastatic cellular vaccines in heterozygous recipients: implications for the T cell repertoire. J. Immunol. 148:3666.
54. Finn, O. J. 1993. Tumor-rejection antigens recognized by T lymphocytes. Curr. Opin. Immunol. 5:701.
55. Boon, T., and P. van der Bruggen. 1996. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183:725.